Daily as of 2 Nov 16:00 ET
- Price
- above both $75.00 vs 50 $70.14 / 200 $72.74
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 16 Oct 2026 · projected 30 bars out
BBIO | BridgeBio PharmaNASDAQHealthcareCommon stock golden cross and death cross projections, cross tests and history
$75.00
+$0.05 (+0.06%)
BridgeBio Pharma (BBIO) is a NASDAQ-listed common stock that Cruxta has tracked for 50/200 crosses since 2020.
The 50 SMA has sat below the 200 on the daily since Oct 2026, with no cross projected inside the 30 bars Cruxta tracks. On both the daily and the weekly, price sits above the 50 and the 200; on the 4-hour it is between the two.
Timeframe summary
Weekly as of 30 Oct 16:00 ET
- Price
- above both $74.95 vs 50 $72.76 / 200 $40.90
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 🟨Golden cross week of 9 Sep 2024 · projected 7 bars out · tested 1 bar
4-hour as of 3 Nov 16:00 ET
- Price
- between the two $74.03 vs 50 $68.04 / 200 $74.48
- Projection
- No cross projected
- Test
- No active test
- Last cross
- 💀Death cross 24 Sep 2026 · projected 26 bars out
Cross history
| Crossed | Direction | Timeframe | Projected | Cross test |
|---|---|---|---|---|
| 16 Oct 2026 | 💀Death steep | daily | 30 bars out | Not tested |
| 24 Sep 2026 | 💀Death | 4-hour | 26 bars out | Not tested |
| 9 Jul 2026 | 🟨Golden | 4-hour | 22 bars out | Not tested |
| 8 May 2026 | 💀Death | 4-hour | 30 bars out | Not tested |
| 23 Apr 2026 | 🟨Golden | 4-hour | 21 bars out | 4 bar cross test |
About BBIO
ExchangeNASDAQ
InstrumentCommon stock
Median $ volume, 60 d$176M
4-hour coverageYes, since Oct 2025
History on recordSince 2020
SectorHealthcare
Cap bandlarge